Breast Cancer Clinical Trials in Houston

Showing 481-500 of 575 trials

Lifestyle Intervention for High Risk Cancer Survivors

NCT01508273

The goal of this behavioral research study is to find out more about the health behaviors of cancer survivors. Researchers want to understand the cultural, social, and environmental factors related to physical activity and personal diet. Researchers also want to learn if cancer survivors who take part in lifestyle interventions have better overall health and quality of life than those who do not take part in these interventions.

Breast Cancer

M.D. Anderson Cancer Center1,150 participantsStarted May 2012

Fort Worth, Texas, United States • Houston, Texas, United States • Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer

NCT00303108

The purpose of this study is to determine the ORR associated with Doxil in combination with carboplatin in HER2- (negative) MBC (and with Herceptin in HER2+ MBC).

Metastatic Breast Cancer

US Oncology Research136 participantsStarted Dec 2005

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Sedona, Arizona, United States +54 more locations

Lifestyle Intervention for High Risk Cancer Survivors

Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer

Breast Cancer Trials in Other Cities

Trial of Neoadjuvant Trastuzumab Emtansine in Patients With HER2-Equivocal Breast Cancer

Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies

Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC)

Delayed-Immediate Breast Reconstruction

Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer

A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy

A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors

A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer

Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer

EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer

Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer

Docetaxel and Carboplatin in Treating Women With Metastatic Breast Cancer

Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer

ICI 182780 in Treating Women With Metastatic Breast Cancer

Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy

Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer

A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function

Other Conditions in Houston